Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules, USP 0.5 mg Due to Dissolution Test Failure


Teva Pharmaceuticals USA has initiated a voluntary nationwide recall of a single lot of Anagrelide Capsules, USP 0.5 mg (Lot number GD01090), to the consumer level in the United States. This voluntary recall was initiated due to dissolution test failure detected during routine stability testing. No (US Food Recalls) More More

Similar stories

Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules - Diagnostic and Interventional Cardiology

Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules  Diagnostic and Interventional Cardiology

Posted on 24 May 2022 | 2:00 am | Google News

Pharma Industry Contends with Contamination-Based Recalls - Pharmaceutical Technology Magazine

Pharma Industry Contends with Contamination-Based Recalls  Pharmaceutical Technology Magazine

Posted on 31 March 2021 | 2:00 am | Google News

Copyright © 2024 LastMinuteStuff.com | Contact info